Cambridge Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $197K | Sell |
471
-120
| -20% | -$50.2K | 0.01% | 265 |
|
2023
Q4 | $240K | Buy |
591
+3
| +0.5% | +$1.22K | 0.01% | 246 |
|
2023
Q3 | $204K | Sell |
588
-1
| -0.2% | -$348 | 0.01% | 258 |
|
2023
Q2 | $207K | Buy |
589
+150
| +34% | +$52.8K | 0.01% | 268 |
|
2023
Q1 | $138K | Hold |
439
| – | – | 0.01% | 318 |
|
2022
Q4 | $127K | Sell |
439
-4
| -0.9% | -$1.16K | 0.01% | 334 |
|
2022
Q3 | $128K | Buy |
443
+74
| +20% | +$21.4K | 0.01% | 328 |
|
2022
Q2 | $104K | Sell |
369
-118
| -24% | -$33.3K | ﹤0.01% | 383 |
|
2022
Q1 | $127K | Sell |
487
-95
| -16% | -$24.8K | ﹤0.01% | 389 |
|
2021
Q4 | $128K | Buy |
+582
| New | +$128K | ﹤0.01% | 394 |
|